Skip to main content

Find Clinical Trials

Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

503 public trials 160 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Recruiting

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

NCT07714538

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +35 more
Locations: Maidstone and Tunbridge Wells NHS Trust Maidstone, Kent, United Kingdom

Liverpool University Hospitals NHS Foundation Trust Liverpool, Merseyside, United Kingdom

NHS Greater Glasgow and Clyde Glasgow, United Kingdom

The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool, United Kingdom

View Trial Details

Recruiting

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)

NCT07161869

Conditions: Adenocarcinoma, Adenocarcinoma of Biliary Tract, Bile Duct Diseases, +18 more
Locations: Erasmus MC University Medical Center Rotterdam, South Holland, Netherlands

Amsterdam University Medical Center Amsterdam, Netherlands

University Medical Center Groningen Groningen, Netherlands

Leiden University Medical Center Leiden, Netherlands

View Trial Details

Recruiting

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma

NCT07780838

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +33 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

NCT06037980

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +9 more
Locations: Ospedali Riuniti di Ancona Ancona, Italy

ASST Papa Giovanni XXIII Bergamo, Italy

Oncologia Medica Policlinico Sant'Orsola - Malpighi Bologna, Italy

ASST Spedali Civili Brescia, Italy

View all 19 locations

View Trial Details

Recruiting

Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma

NCT06175845

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +20 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Germany

Charite Berlin, Germany

University Medical Center Bonn, Germany

Clinic Chemnitz Chemnitz, Germany

View Trial Details

Recruiting

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

NCT07282912

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Ampullary Adenocarcinoma, +13 more
Locations: Smilow Cancer Center New Haven, Connecticut, United States

View Trial Details

Recruiting

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

NCT01915225

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +26 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions: Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations: Stanford University Palo Alto, California, United States

Grand Valley Oncology Grand Junction, Colorado, United States

Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States

Sylvester Comprehensive Cancer Center Miami, Florida, United States

View all 26 locations

View Trial Details

Recruiting

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

NCT06728410

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recruiting

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

NCT05286814

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +33 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details